News | January 11, 2024
Aarti Pharmalabs sets up R&D Centre in Navi Mumbai
The R&D centre is mainly dedicated to the Process R&D of New Chemical Entities (NCE) development projects
The R&D centre is mainly dedicated to the Process R&D of New Chemical Entities (NCE) development projects
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
This agreement includes upfront and milestone payments with a combined potential value of over $500m and sales royalties.
Base4's drug discovery platform allows its collaborators to evaluate billions of novel small molecules to identify and progress RNA-modulators for important diseases
Vyleesi is the first and only as-needed treatment approved by the Food and Drug Administration (FDA) for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD)
Elpiscience will receive up to US $37 million, including the upfront payment and license option fees
Studies have demonstrated that ZYIL1 is highly potent and can suppress inflammation caused by NLRP3 inflammasome activation
Acquisition underscores Merck’s ongoing commitment to developing treatments for neurodegenerative diseases
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
Subscribe To Our Newsletter & Stay Updated
